scholarly journals Autophagy-deficient breast cancer shows early tumor recurrence and escape from dormancy

Oncotarget ◽  
2018 ◽  
Vol 9 (31) ◽  
pp. 22113-22122 ◽  
Author(s):  
Hussein F. Aqbi ◽  
Liliya Tyutyunyk-Massey ◽  
Rebecca C. Keim ◽  
Savannah E. Butler ◽  
Theresa Thekkudan ◽  
...  
2016 ◽  
Vol 65 (4) ◽  
pp. 719-726 ◽  
Author(s):  
María Reig ◽  
Zoe Mariño ◽  
Christie Perelló ◽  
Mercedes Iñarrairaegui ◽  
Andrea Ribeiro ◽  
...  

2007 ◽  
Vol 7 (2) ◽  
pp. 315-325 ◽  
Author(s):  
Xin Yi ◽  
John M. Luk ◽  
Nikki P. Lee ◽  
Jirun Peng ◽  
Xisheng Leng ◽  
...  

2009 ◽  
Vol 174 (6) ◽  
pp. 2023-2034 ◽  
Author(s):  
Agnieszka K. Witkiewicz ◽  
Abhijit Dasgupta ◽  
Federica Sotgia ◽  
Isabelle Mercier ◽  
Richard G. Pestell ◽  
...  

2018 ◽  
Vol 6 (3) ◽  
pp. 209-217 ◽  
Author(s):  
Fernando Santos-Pinheiro ◽  
Mingjeong Park ◽  
Diane Liu ◽  
Lawrence N Kwong ◽  
Savannah Cruz ◽  
...  

Abstract Background Low-grade gliomas (LGGs) are slow-growing, infiltrative tumors frequently associated with seizures. Predicting which patients will develop early tumor recurrence based on clinical indicators following initial surgical intervention remains a challenge. Seizure recurrence following surgery may be an early indicator of tumor recurrence, especially in patients presenting with increase in seizure frequency. Methods This study analyzed 148 patients meeting inclusion criteria (age >18 years, LGG diagnosis, at least 1 seizure event recorded before and after initial surgical intervention). All patients were treated at the Brain and Spine Center at The University of Texas MD Anderson Cancer Center from January 2000 to March 2013. Seizure frequency in a 6-month period before and after tumor resection was categorized as none, 1, few (2 to 3 seizures) or several (>3 seizures). Immediately postoperative seizures (up to 48 hours from surgery) were not included in the analysis. Results A total of 116 (78.4%) patients had seizures at initial presentation and most (95%) were started on antiepileptic drugs (AEDs). We found 2 clinical variables with a significant impact on progression-free survival (PFS): Higher seizure frequency during the 6-month postoperative period and seizure frequency increase between the 6-month pre- and the 6-month postoperative periods were both correlated to higher risk of early tumor recurrence (P = .007 and P = .004, respectively). Conclusion Seizure frequency following surgical resection of LGGs and the seizure frequency change between the 6-month preoperative and postoperative periods may serve as clinical predictors of early tumor recurrence in patients with LGGs who are also afflicted by seizures.


Sign in / Sign up

Export Citation Format

Share Document